Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$3.27 - $8.76 $35,643 - $95,484
10,900 Added 25.23%
54,100 $187,000
Q1 2022

May 12, 2022

BUY
$7.56 - $14.3 $326,592 - $617,760
43,200 New
43,200 $354,000
Q3 2021

Nov 12, 2021

SELL
$16.69 - $26.05 $491,236 - $766,729
-29,433 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$18.15 - $27.75 $223,172 - $341,214
-12,296 Reduced 29.47%
29,433 $745,000
Q1 2021

May 17, 2021

BUY
$20.71 - $51.02 $864,207 - $2.13 Million
41,729 New
41,729 $1.03 Million
Q4 2020

Feb 12, 2021

SELL
$21.84 - $44.0 $444,771 - $896,060
-20,365 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$13.63 - $24.12 $277,574 - $491,203
20,365 New
20,365 $441,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $223M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.